Formulation breakthroughs driving broader tyrosine kinase use

Authors

Institutions

Publication Details

Journal
British Journal of Clinical Pharmacology
Published
2026-02-18
DOI
https://doi.org/10.1002/bcp.70489
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formulation breakthroughs driving broader tyrosine kinase use

Charlotta Liljebris, Gérald Jesson, Leif Stenke, Per Andersson et al.
British Journal of Clinical Pharmacology
Pharmacogenetics and Drug Metabolism
article

Formulation breakthroughs driving broader tyrosine kinase use

Charlotta Liljebris, Gérald Jesson, Leif Stenke, Per Andersson, Magnus Brisander, Hans Lennernäs, Mikael von Euler, Claes‐Henrik Andersson
article en

Abstract

No abstract available for this paper.
British Journal of Clinical Pharmacology
Uppsala University (SE), Karolinska University Hospital (SE), Xbrane Biopharma (Sweden) (SE)
Responsible consumption and production
Openalex Percentile: Top 50%
Pharmacogenetics and Drug Metabolism
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.